 Pear Therapeutics Inc. NASDAQ:PEAR Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Meara Murphy Senior Director-Corporate Communications Corey McCann President and Chief Executive Officer Ronan OBrien General Counsel Julia Strandberg Chief Commercial Officer Yuri Maricich Chief Medical Officer Chris Guiffre Chief Financial Officer and Chief Operating Officer Erin Brenner Chief Product Development Officer Conference Call Participants Eric Percher Nephron Research Marie Thibault BTIG Neena Bitritto-Garg Citi Steve Braun Cowen Keay Nakae Chardan Rahul Rakhit LifeSci Capital Operator Good afternoon, everyone. Welcome to the Pear Therapeutics Third Quarter 2022 Earnings Conference Call. 